当前位置:首页 - 行情中心 - 金城医药(300233) - 财务分析 - 资产负债表

金城医药

(300233)

  

流通市值:62.01亿  总市值:64.30亿
流通股本:3.70亿   总股本:3.84亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金1,116,070,894.64921,597,083.14926,336,241.84859,028,154.4
衍生金融资产88,636.11--102,047.81
应收票据及应收账款634,573,915.91576,591,450.13592,823,487.38669,869,887.5
其中:应收票据71,296,336.9245,216,00016,899,284.3289,310,363.62
应收账款563,277,578.99531,375,450.13575,924,203.06580,559,523.88
应收款项融资144,517,656.23189,915,894.08175,217,524.06133,515,617.13
预付款项27,628,291.4330,927,938.2241,391,067.1931,465,350.38
其他应收款合计9,221,783.8810,362,123.8310,263,503.78,030,684.03
存货473,767,851.28558,191,958.23576,607,625.2579,217,125.83
其他流动资产11,216,565.68,119,031.3219,029,801.4926,920,278.91
流动资产平衡项目0000
流动资产合计2,417,085,595.082,295,705,478.952,341,669,250.862,308,149,145.99
非流动资产:
长期股权投资19,558,679.9419,645,602.1519,556,722.6214,802,516.67
其他权益工具投资135,584,764.93135,584,764.93133,766,598.2126,418,288.36
固定资产2,336,389,576.182,327,423,151.892,336,016,518.572,343,569,734.05
在建工程127,346,754.29103,970,973.67106,885,308.97121,307,085
使用权资产6,043,374.875,408,408.145,263,995.563,795,421.19
无形资产539,012,199.32542,871,406.49466,233,521.76452,198,206.52
开发支出284,695,294.94303,695,209.23369,105,172.1353,254,597.81
长期待摊费用15,966,442.4216,776,923.8713,726,709.7816,335,836.29
递延所得税资产53,316,084.3654,261,337.1951,077,793.8451,879,569.05
其他非流动资产10,321,628.7931,904,707.843,917,758.1434,373,190.04
非流动资产平衡项目0000
非流动资产合计3,528,234,800.043,541,542,485.363,545,550,099.543,517,934,444.98
资产平衡项目0000
资产总计5,945,320,395.125,837,247,964.315,887,219,350.45,826,083,590.97
流动负债:
短期借款194,000,000203,750,000242,886,000212,886,000
衍生金融负债-162,406.14232,637.63-
应付票据及应付账款723,202,382.54706,416,833.18716,716,777.54726,050,680.36
其中:应付票据228,199,781.36158,017,269.89140,767,074.2141,516,559.57
应付账款495,002,601.18548,399,563.29575,949,703.34584,534,120.79
合同负债68,443,842.3138,535,601.1841,255,997.4644,665,382.25
应付职工薪酬169,124,491.71147,172,732.82132,432,615.38184,098,204.44
应交税费29,417,781.0937,291,527.7334,459,814.7755,458,370.12
其他应付款合计347,183,496.55320,631,948.21299,058,342.74309,704,523.35
应付股利-3,199,700--
一年内到期的非流动负债69,642,985.42155,406,041.03150,990,712.26164,314,972.96
其他流动负债7,219,952.592,885,473.752,790,796.73,760,327.97
流动负债平衡项目0000
流动负债合计1,608,234,932.211,612,252,564.041,620,823,694.481,700,938,461.45
非流动负债:
长期借款398,787,959.47293,944,435.04345,606,526.52271,690,940.29
租赁负债3,615,818.912,852,404.453,287,538.132,018,994
递延收益61,925,737.3164,393,414.2563,542,964.3265,995,598.68
递延所得税负债129,984,910.16131,763,329.59125,976,476.43126,127,539.48
非流动负债平衡项目0000
非流动负债合计594,314,425.85492,953,583.33538,413,505.4465,833,072.45
负债平衡项目0000
负债合计2,202,549,358.062,105,206,147.372,159,237,199.882,166,771,533.9
所有者权益(或股东权益):
实收资本(或股本)385,924,427385,924,427387,410,987387,410,987
资本公积2,358,652,311.42,385,487,662.392,402,591,152.932,397,214,060.07
减:库存股33,002,42433,002,42456,936,04056,936,040
其他综合收益35,435,833.2935,435,833.2933,890,391.5728,379,159.19
专项储备7,541,739.326,002,488.363,743,883.46952,283.86
盈余公积115,815,925.36115,815,925.36115,815,925.36115,815,925.36
未分配利润809,903,753.38778,419,470.21784,756,345.58734,601,690.25
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计3,680,271,565.753,674,083,382.613,671,272,645.93,607,438,065.73
少数股东权益62,499,471.3157,958,434.3356,709,504.6251,873,991.34
股东权益平衡项目0000
股东权益合计3,742,771,037.063,732,041,816.943,727,982,150.523,659,312,057.07
负债和股东权益合计5,945,320,395.125,837,247,964.315,887,219,350.45,826,083,590.97
公告日期2023-10-252023-08-192023-04-272023-03-31
审计意见(境内)标准无保留意见
TOP↑